REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,912,000 | +281.6% | 72,489 | +1355.3% | 0.07% | +173.1% |
Q3 2021 | $501,000 | -27.9% | 4,981 | +1.4% | 0.03% | -13.3% |
Q2 2021 | $695,000 | -25.8% | 4,912 | -47.7% | 0.03% | -42.3% |
Q1 2021 | $937,000 | +346.2% | 9,400 | +452.9% | 0.05% | +205.9% |
Q4 2020 | $210,000 | -41.8% | 1,700 | -32.0% | 0.02% | -61.4% |
Q1 2020 | $361,000 | – | 2,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
IFP Advisors, Inc | 300 | $51,708 | 0.00% |